Translational Cancer Research

Journal Title

Translational Cancer Research

TRANSL CANCER RES

ISSN / eISSN

2218-676X / 2219-6803

Aims and Scope

Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.

Subject Area

ONCOLOGY

CiteScore

2.10 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Radiology, Nuclear Medicine and Imaging	Q3	#209/333
Medicine - Oncology	Q3	#271/404
Medicine - Cancer Research	Q4	#183/230

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2024)	Quartile
ONCOLOGY	Q4

H-index

22

Country/Area of Publication

PEOPLES R CHINA

Publisher

AME Publishing Company

Annual Article Volume

261

Open Access

NO

Contact

FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, PEOPLES R CHINA, HONG KONG, 00000